Advanced resuscitation strategies for cardiac arrest in pregnancy: a systematic review Authors: Takashi Hongo, Tetsuya Yumoto, Takafumi Obara, Tomohiro Hiraoka, Yoshinori Kosaki, Shunta Jinno, Ippei Matsuo, Misa Sasanami, Yuya Miyoshi, Shodai Yoshihiro, Takahiro Tsuge, Atsunori Nakao, Hiromichi Naito Published: 2026 ABSTRACT BackgroundCardiac arrest during pregnancy is a rare, life-threatening event. The roles of resuscitative delivery (RD) and extracorporeal cardiopulmonary resuscitation (ECPR) remain unclear. This systematic review summarizes maternal and neonatal outcomes according to initial resuscitation strategy.MethodsThis systematic review followed a preplanned protocol registered in the Open Science Framework and adhered to PRISMA guidelines. MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and Igaku Chuo Zasshi were searched from inception to May 8, 2025, without language restrictions. Cases were categorized by initial resuscitation strategy into four groups: RD–/ECPR–, RD+/ECPR–, RD–/ECPR+, and RD+/ECPR+.ResultsA total of 150 studies were included, comprising predominantly case reports and describing 268 pregnant patients with cardiac arrest and 274 neonates from 34 countries (2000–2025). Initial resuscitation strategies were RD–/ECPR– in 71/268 (26.5%), RD+/ECPR– in 184/268 (68.7%), RD–/ECPR + in 5/268 (1.9%), and RD+/ECPR + in 8/268 (3.0%). Favorable neurological outcomes were reported in 37/61 (61.9%), 39/146 (26.7%), 4/5 (80.0%), and 2/8 (25.0%), respectively, among cases with available data. Maternal survival beyond ICU admission (mid-term survival) was observed in 46/66 (69.7%), 69/171 (40.3%), 5/5 (100%), and 6/8 (75.0%), respectively. Neonatal survival beyond ICU admission was observed in 29/58 (50.0%), 61/101 (60.4%), 3/5 (60.0%), and 4/7 (57.1%). Among cases receiving both RD and ECPR, ECPR was initiated after RD in six cases and preceded RD in one case.ConclusionsMaternal and neonatal outcomes after cardiac arrest during pregnancy varied widely across resuscitation strategies. The available evidence is limited by small, case-based reports, highlighting the need for large registries and multicenter studies to define the optimal use and sequencing of RD and ECPR.Trial registrationA preplanned protocol for systematic review has been registered in the Open Science Framework (Osf.io) [https://osf.io/9xsrt/files/osfstorage].Supplementary InformationThe online version contains supplementary material available at 10.1186/s12872-026-06080-5. Background Cardiac arrest in pregnancy is a rare but life-threatening clinical event associated with high maternal and neonatal morbidity and mortality [1]. Although the prevalence of cardiac arrest during pregnancy is estimated at approximately 0.12%, it is increasing [2–4]. Because of its rarity, resuscitation during pregnancy remains a major challenge. However, high-quality evidence is scarce, owing to ethical constraints and limited case numbers [5, 6]. Current resuscitation guidelines emphasize maternal survival as the primary goal and recommend high-quality cardiopulmonary resuscitation (CPR) with pregnancy-specific modifications. In the absence of return of spontaneous circulation (ROSC), early consideration of resuscitative delivery (RD) is recommended, supported by physiological reasoning that uterine evacuation relieves aortocaval compression and improves venous return and cardiac output [5, 6]. However, the role of mechanical circulatory support in pregnancy cases refractory to conventional resuscitative measures remains unclear. Extracorporeal cardiopulmonary resuscitation (ECPR) has been increasingly recognized as a rescue therapy for refractory cardiac arrest [7]. Although maternal survival following ECPR implementation during pregnancy has been reported in case reports [8], the clinical role, optimal indications, and timing of ECPR in maternal cardiac arrest remain uncertain [8]. Bleeding and thrombotic complications in pregnant patients have raised concerns, which have been recognized as important considerations limiting the use of extracorporeal membrane oxygenation (ECMO) support in the peripartum setting and continuing to complicate the clinical decision-making process [9, 10]. Moreover, data on combined RD and ECPR strategies are scarce, limiting assessment of their clinical effectiveness, appropriate indications, and optimal sequencing. Although combined RD and ECPR approaches may offer theoretical benefits, they introduce additional complexity and the potential risk of bleeding, and their overall value remains uncertain. Because of limited available data, clinicians managing maternal cardiac arrest are frequently required to make time-critical decisions regarding escalation of circulatory support in the absence of robust evidence. Therefore, a comprehensive synthesis of reported maternal and neonatal outcomes across different initial resuscitation strategies is needed. This systematic review summarizes maternal and neonatal outcomes after cardiac arrest during pregnancy according to initial resuscitation strategy, including conventional CPR, RD, ECPR, and combined approaches, and describes implications for clinical practice. Methods Study design A preplanned protocol for systematic review has been registered in the Open Science Framework (Osf.io) [11]. This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [12] and explained the details of the search methodology employed in the case-based review [13]. No ethical approval or patient consent was required. The keywords in PRISMA are shown in Additional File 1. Population, intervention, comparator, outcome, time frame, and study design (PICOST) framework Based on the PICOST template, the review question was formulated as follows. The population (P) comprised pregnant patients with cardiac arrest in any clinical setting, including out-of-hospital and in-hospital settings. The interventions and comparators (I/C) of interest included resuscitative strategies applied during cardiac arrest, defined as conventional CPR, RD, ECPR, and combinations of RD and ECPR. The outcomes (O) were maternal and neonatal clinical outcomes, including survival and neurological outcomes. No restrictions were applied on the time frame (T). Eligible study designs (S) included randomized trials, non-randomized controlled trials, observational studies, case series, and case reports. Eligibility criteria We summarized the initial resuscitation approaches in pregnancy with subsequent maternal and neonatal outcomes. We included studies that reported outcomes of pregnant women and neonates. We did not restrict resuscitation methods; i.e., we included not only CPR but also RD, and/or ECPR. Patients who experienced cardiac arrest following spontaneous vaginal delivery or cesarean section were excluded from the study. Furthermore, studies in which the resuscitation methods were not clearly specified were also excluded. We included randomized trials, non-randomized controlled trials, observational studies (cohort studies and case-control studies), case series (defined as two or more patient cases), and case reports, as the prevalence of cardiac arrest in pregnancy is rare [4]. Letters to the editor were only included if they described a case report that met the intervention inclusion and exclusion criteria. Animal studies, ecological studies, reviews, editorials, abstracts, and commentaries were excluded. We did not apply language or country restrictions. Literature search A comprehensive literature search was performed on May 8, 2025 for this systematic review using the MEDLINE (PubMed: January 1950 to May 2025), Cochrane Central Register of Controlled Trials (Cochrane Library: Issue 1, 2025), Embase (Dialog: January 1980 to May 2025), and Japana Centra Revuo Medicina (Igaku Chuo Zasshi: 1983 to 2025) databases, with no restrictions on language or publication date, to identify studies on outcomes and resuscitation strategies for cardiac arrest during pregnancy. To improve clinical relevance and reduce temporal heterogeneity, we restricted the primary analysis to studies published from 2000 onward. This decision was based on the recognition that major resuscitation guidelines, including those addressing cardiac arrest in pregnancy, have evolved substantially since around 2000, leading to significant changes in clinical practice [14]. The complete searches can be found in Additional File 2. Study selection After removing duplicate articles, pairs of nine authors (TY, TO, YK, JM, TH, YM, SJ, MS, TH) independently reviewed each abstract for consideration of full text review. Any disagreement regarding inclusion or exclusion was resolved via discussion between the reviewers and with a third reviewer (HN) as needed. Then, each author independently reviewed the full text articles for inclusion in the systematic review. Any disagreement regarding eligibility was resolved via discussion. Once final articles were selected, data were extracted by five authors (JM, TH, YM, SJ, MS) and validated by another author (TH). Google Translate was used for non-English texts and information was collected from adequately translated articles for those that met inclusion criteria. Any discrepancies were resolved by discussion. Interpretation of data Relevant outcomes were prespecified based on data previously reported in the literature. For descriptive purposes, maternal cardiac arrest patients were grouped according to the reported resuscitation approach into four categories: without RD or ECPR (RD–/ECPR–), RD only (RD+/ ECPR–), ECPR only (RD–/ ECPR+), and combined RD and ECPR (RD+/ ECPR+). We extracted data referring to study characteristics such as (1) authors, publication year, study type, location of arrest (out-of-hospital cardiac arrest (OHCA) or in-hospital cardiac arrest (IHCA), and country where the study was conducted; (2) sample size, number of patients with reported outcomes at any time interval after arrest, and baseline characteristics of cardiac arrest (age, gestational age, bystander CPR, witness status, initial rhythm, CPR duration, resuscitation procedure, etiology of cardiac arrest, ECPR, RD). We attempted to contact the authors of the studies to collect sufficient information if necessary. To ensure data quality and consistency, a standardized data extraction form was developed and piloted on a subset of included studies prior to full data extraction. Outcome data Survival and neurological status were assessed for both maternal and neonatal populations. Maternal outcomes included survival to intensive care unit (ICU) admission, mid-term survival, and mid-term neurological outcomes assessed using the Cerebral Performance Category (CPC) scale [15]. Given the substantial heterogeneity in reported follow-up time points across studies (e.g., ICU discharge, hospital discharge, 30-day, 90-day, or one-year outcomes), survival and neurological outcomes beyond ICU admission were categorized as mid-term outcomes defined as the latest available follow-up reported in each study. When multiple time points were available, data from the longest reported follow-up were preferentially extracted. Furthermore, the interval from CPR initiation to ROSC was documented. In patients managed with ECPR, the time from CPR initiation to ROSC was considered as a proxy measure for the interval from CPR initiation to ECPR initiation. Neonatal outcomes included requirements for ventilatory support or CPR after delivery, survival to ICU admission, mid-term survival, and mid-term neurological outcomes based on Pediatric Cerebral Performance Category (PCPC) [16]. A favorable neurological outcome was defined as a CPC score of 1 or 2 in adult patients and a PCPC score of 1 or 2 in pediatric patients [17, 18]. Because both RD and ECPR are frequently associated with substantial hemorrhage and may require large-volume transfusion, we extracted data on maternal blood product use when available. Specifically, we collected information on the number of red blood cell (RBC) units and fresh frozen plasma (FFP) units administered during resuscitation and/or the in-hospital course. When reported, the total number of units transfused per patient was recorded. Statistical analysis The relevant data from the included studies was summarized using Microsoft Excel (Microsoft Corp., Redmond, WA, USA) and Stata version 19 (StataCorp LP, College Station, TX, USA). Given the descriptive nature of this study, data were summarized using descriptive statistics, including medians and proportions. Missing values were excluded from the analysis. Quality assessment Two or more reviewers independently assessed the methodological quality of the studies, and discrepancies were resolved by discussion. If necessary, a third author helped to reach agreement. The quality assessment of risk of bias for the included case [19] or case series [20] was conducted using the Joanna Briggs Institute (JBI) critical appraisal tools. The methodological quality was assessed by the Quality in Prognosis Studies (QUIPS) tool, which has been recommended by the Cochrane Prognosis Methods Group [21]. The following six domains are considered: (1) study participation, (2) study attrition, (3) measures of risk factors, (4) measurement of and controlling for confounding variables, (5) outcome measures, (6) analysis and reporting. Each domain was assessed as having high, moderate, or low risk of bias (RoB). Overall RoB was also assessed. We considered a study to be of high quality when the RoB was rated low on at least four of the six domains and rated low for both study attrition and study confounding [22]. Subgroup and sensitivity analysis To explore whether the effects of resuscitation strategies differed across patient characteristics, subgroup analyses were conducted. Subgroup comparisons were performed according to the sequence of RD and ECPR (RD-first vs. ECPR-first), cardiac arrest location (OHCA vs. IHCA), etiology (amniotic fluid embolism), gestational age (≥ 20 weeks), and calendar period (2000–2009, 2010–2014, 2015–2019, and 2020-), aligned with major updates in international resuscitation guidelines (e.g., 2000, 2010, 2015, and 2020), to capture temporal changes in recommended resuscitation strategies and clinical practice. Furthermore, to assess the robustness of the findings, a sensitivity analysis was conducted restricting the population to patients with witnessed cardiac arrest, patients who received bystander CPR, and patients with shockable initial rhythm. Protocol deviation Outcome time points (ICU admission, hospital discharge, and 30-day outcomes) were prespecified; however, substantial heterogeneity in outcome reporting across the included studies precluded their consistent application. Accordingly, to improve comparability and minimize missing data, reported follow-up time points beyond ICU admission were aggregated into broader mid-term outcome categories, defined as the longest available follow-up reported in each study. The original protocol specified subgroup analyses according to the sequence of RD and ECPR; additional subgroup and sensitivity analyses were performed to further explore patterns observed in the data. These analyses were exploratory in nature and are summarized descriptively. In addition, although no restriction on publication date was specified in the original protocol, the analysis was restricted to studies published from 2000 onward to improve clinical relevance and reduce temporal heterogeneity, given the substantial evolution of resuscitation practices. Furthermore, while the protocol prespecified that continuous variables would be summarized as means with standard deviations, continuous variables are reported as medians with interquartile ranges (IQRs) in the present analysis owing to non-normal data distributions. Results The literature search retrieved 2,911 records, of which 1,159 were duplicates and subsequently removed. The remaining 1,752 titles and abstracts underwent screening, yielding 354 articles eligible for full-text review. Following comprehensive evaluation according to predefined criteria, 150 studies fulfilled inclusion requirements, comprising 9 observational investigations, 11 case series, and 130 individual case reports (Fig. 1). Consequently, these reports described 268 pregnant patients experiencing cardiac arrest and 274 neonates across 34 countries, with publication years ranging from 2000 to 2025. Fig. 1Flow chart of patients analyzed Flow chart of patients analyzed Initial strategies and patient characteristics Patients were categorized as conventional CPR without RD or ECPR (RD–/ECPR–) (71/268, 26.5%; corresponding to 82 neonates), RD-only (RD+/ECPR–) (184/268, 68.7%; 189 neonates), ECPR-only (RD–/ECPR+) (5/268, 1.9%; 5 neonates), and combined ECPR and RD (RD+/ECPR+) (8/268, 3.0%; 9 neonates) (Table 1). Median gestational age varied across the four groups, with medians of 28 weeks (IQR, 18–36), 35 weeks (IQR, 31–37), 28 weeks (IQR, 25–34), and 36 weeks (IQR, 32–38), respectively. A gestational age of ≥ 20 weeks was present in 72.8% (43/67) of patients in the RD–/ECPR– group and in 100% of patients in each of the other groups. IHCA occurred in 56.3% (36/64), 59.0% (69/117), 100% (5/5), and 50.0% (4/8) of the four groups, whereas OHCA occurred in 43.7% (28/64), 41.0% (48/117), 0% (0/5), and 50.0% (4/8), respectively. Bystander CPR (85.4–100%) and witnessed arrest (93.2–100%) were consistently high. Shockable rhythms were most frequent in the RD+/ECPR– group (55/76, 72.2%). Amniotic fluid embolism was identified in 15.4% (11/71), 7.6% (14/184), 40.0% (2/5), and 37.5% (3/8) of patients across the four groups. Median CPR duration varied across strategies, with values of 14 min (IQR, 4–23), 21 min (IQR, 11–45), 28 min (IQR, 26–49), and 32 min (IQR, 21–90), respectively. In the OHCA settings, prehospital ROSC was uncommon, ranging from 0% to 16.7%. Table 1Patient CharacteristicsVariablesRD-/ECPR-n = 71RD+/ECPR-n = 184RD-/ECPR+n = 5RD+/ECPR+n = 8Location, n (%) OHCA28/64 (43.7)48/117 (41.0)0/5 (0)4/8 (50.0) IHCA36/64 (56.3)69/117 (59.0)5/5 (100)4/8 (50.0)Age (years), median (IQR)32 (28–37)30 (26–36)33 (30–33)35 (31–39)Gestational age (weeks)28 (18–36)35 (31–37)28 (25–34)36 (32–38)≥ 20 weeks43/67 (72.8)105/105 (100)5/5 (100)8/8 (100)Bystander CPR, n (%)45/49 (91.8)82/96 (85.4)5/5 (100)7/7 (100)Witness, n (%)4750 (94.0)83/89 (93.2)5/5 (100)7/7 (100)Initial rhythm on the sceneShockable rhythm18/51 (41.8)55/76 (72.2)2/3 (66.6)3/6 (50.0) Ventricular fibrillation8/51 (18.6)30/76 (39.4)2/3 (66.6)0/6 (0) Ventricular tachycardia10/51 (23.2)25/76 (32.8)0/3 (0)3/6 (50.0) Pulseless electrical activity2/51 (4.6)6/76 (7.8)0/3 (0)0/6 (0) Asystole19/51 (44.1)12/76 (15.7)1/3 (33.3)2/6 (33.3)Prehospital ROSC4/43 (9.3)3/76 (3.1)0/3 (0)1/6 (16.7)Etiology, n (%) AFE11/71 (15.4)14/184 (7.6)2/5 (40.0)3/8 (37.5) Obstetric causes (non-AFE)5/71 (7.0)15/184 (8.1)0/5 (0)1/8 (12.5) Trauma4/71 (5.6)15/184 (8.1)0/5 (0)0/8 (0) Cardiovascular15/71 (21.1)8/184 (4.3)1/5 (20.0)0/8 (0) Respiratory8/71 (11.2)15/184 (8.1)1/5 (20.0)3/8 (37.5) Anesthesia-related causes1/71 (1.4)5/184 (2.7)0/5 (0)0/8 (0) Non-traumatic hemorrhagic causes2/71 (2.8)4/184 (2.1)0/5 (0)0/8 (0) Infection0/71 (0)1/184 (0.5)0/5 (0)0/8 (0) Metabolic/endocrine4/71 (5.6)5/184 (2.7)0/5 (0)0/8 (0) Unknown21/71 (29.5)102/184 (55.4)1/5 (20.0)1/8 (12.5)CPR duration14 (4–23)21 (11–45)28 (26–49)32 (21–90)Collapse to ECMO implantation (minutes), median (IQR)NANA30 (28–49)41 (26–75)Collapse to PMCS initiation (minutes), median (IQR)NA14 (6–30)NA23 (5–60)ECPR firstNANANA1/7 (14.3)AFE Amniotic fluid embolism, IHCA In-hospital cardiac arrest, IQR Interquartile range, CPR Cardiopulmonary resuscitation, OHCA Out-of-hospital cardiac arrest, ROSC Return of spontaneous circulation, ECMO Extracorporeal membrane oxygenation, ECPR Extracorporeal cardiopulmonary resuscitation, n number, RD Resuscitative delivery Table 1Patient CharacteristicsVariablesRD-/ECPR-n = 71RD+/ECPR-n = 184RD-/ECPR+n = 5RD+/ECPR+n = 8Location, n (%) OHCA28/64 (43.7)48/117 (41.0)0/5 (0)4/8 (50.0) IHCA36/64 (56.3)69/117 (59.0)5/5 (100)4/8 (50.0)Age (years), median (IQR)32 (28–37)30 (26–36)33 (30–33)35 (31–39)Gestational age (weeks)28 (18–36)35 (31–37)28 (25–34)36 (32–38)≥ 20 weeks43/67 (72.8)105/105 (100)5/5 (100)8/8 (100)Bystander CPR, n (%)45/49 (91.8)82/96 (85.4)5/5 (100)7/7 (100)Witness, n (%)4750 (94.0)83/89 (93.2)5/5 (100)7/7 (100)Initial rhythm on the sceneShockable rhythm18/51 (41.8)55/76 (72.2)2/3 (66.6)3/6 (50.0) Ventricular fibrillation8/51 (18.6)30/76 (39.4)2/3 (66.6)0/6 (0) Ventricular tachycardia10/51 (23.2)25/76 (32.8)0/3 (0)3/6 (50.0) Pulseless electrical activity2/51 (4.6)6/76 (7.8)0/3 (0)0/6 (0) Asystole19/51 (44.1)12/76 (15.7)1/3 (33.3)2/6 (33.3)Prehospital ROSC4/43 (9.3)3/76 (3.1)0/3 (0)1/6 (16.7)Etiology, n (%) AFE11/71 (15.4)14/184 (7.6)2/5 (40.0)3/8 (37.5) Obstetric causes (non-AFE)5/71 (7.0)15/184 (8.1)0/5 (0)1/8 (12.5) Trauma4/71 (5.6)15/184 (8.1)0/5 (0)0/8 (0) Cardiovascular15/71 (21.1)8/184 (4.3)1/5 (20.0)0/8 (0) Respiratory8/71 (11.2)15/184 (8.1)1/5 (20.0)3/8 (37.5) Anesthesia-related causes1/71 (1.4)5/184 (2.7)0/5 (0)0/8 (0) Non-traumatic hemorrhagic causes2/71 (2.8)4/184 (2.1)0/5 (0)0/8 (0) Infection0/71 (0)1/184 (0.5)0/5 (0)0/8 (0) Metabolic/endocrine4/71 (5.6)5/184 (2.7)0/5 (0)0/8 (0) Unknown21/71 (29.5)102/184 (55.4)1/5 (20.0)1/8 (12.5)CPR duration14 (4–23)21 (11–45)28 (26–49)32 (21–90)Collapse to ECMO implantation (minutes), median (IQR)NANA30 (28–49)41 (26–75)Collapse to PMCS initiation (minutes), median (IQR)NA14 (6–30)NA23 (5–60)ECPR firstNANANA1/7 (14.3)AFE Amniotic fluid embolism, IHCA In-hospital cardiac arrest, IQR Interquartile range, CPR Cardiopulmonary resuscitation, OHCA Out-of-hospital cardiac arrest, ROSC Return of spontaneous circulation, ECMO Extracorporeal membrane oxygenation, ECPR Extracorporeal cardiopulmonary resuscitation, n number, RD Resuscitative delivery Patient Characteristics AFE Amniotic fluid embolism, IHCA In-hospital cardiac arrest, IQR Interquartile range, CPR Cardiopulmonary resuscitation, OHCA Out-of-hospital cardiac arrest, ROSC Return of spontaneous circulation, ECMO Extracorporeal membrane oxygenation, ECPR Extracorporeal cardiopulmonary resuscitation, n number, RD Resuscitative delivery Maternal outcomes Survival to ICU admission occurred in 51/64 (79.6%) for RD–/ECPR–, 63/110 (57.2%) for RD+/ECPR–, 5/5 (100%) for RD–/ECPR+, and 7/8 (87.5%) for RD+/ECPR+. The median time from CPR initiation to ROSC was 9 min (IQR, 4–22), 15 min (IQR, 8–29), 28 min (IQR, 26–30), and 58 min (IQR, 26–86), respectively. Mid-term survival was observed in 46/66 (69.7%), 69/171 (40.3%), 5/5 (100%), and 6/8 (75.0%) patients, respectively. Favorable neurological outcomes were achieved in 37/61 (61.9%), 39/146 (26.7%), 4/5 (80.0%), and 2/8 (25.0%), respectively (Table 2). Table 2Maternal and neonatal outcomesVariablesRD-/ECPR-n = 71 (N = 71)RD+/ECPR-n = 184 (N = 189)RD-/ECPR+n = 5 (N = 5)RD+/ECPR+n = 8 (N = 9)Maternal outcomes, n (%) Survival to intensive care unit admission51/64 (79.6)63/110 (57.2)5/5 (100)7/8 (87.5) CPR initiation to ROSC time9 (4–22)15 (8–29)28 (26–30)58 (26–86) Mid-term survival46/66 (69.7)69/171 (40.3)5/5 (100)6/8 (75.0) Mid-term favorable neurological outcome37/61 (61.9)39/146 (26.7)4/5 (80.0)2/8 (25.0)Neonatal outcome, N (%) Requirement for ventilation after delivery11/33 (33.3)55/77 (71.4)2/4 (50.0)6/7 (85.7) Requirement for CPR after delivery3/31 (9.6)38/78 (48.7)1/4 (25.0)5/7 (71.4) Survival to intensive care unit admission21/42 (50.0)75/103 (72.8)3/5 (60.0)5/7 (71.4) Mid-term survival29/58 (50.0)61/101 (60.4)3/5 (60.0)4/7 (57.1) Mid-term favorable neurological outcome23/57 (40.3)52/94 (55.3)3/5 (60.0)1/5 (20.0)Amount of RBC transfusion after cardiac arrest (U), median (IQR)15 (8–22)11 (2–37)9 (2–17)54 (41–58)Amount of FFP transfusion after cardiac arrest (U), median (IQR)13 (4–24)8 (0–18)4 (0–7)38 (34–44)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, FFP Fresh frozen plasma, IQR Interquartile range, n N, number, RBC Red blood cell, RD Resuscitative delivery, ROSC Return of spontaneous circulation, U Unitn: Maternal sample sizeN: Neonatal sample size Table 2Maternal and neonatal outcomesVariablesRD-/ECPR-n = 71 (N = 71)RD+/ECPR-n = 184 (N = 189)RD-/ECPR+n = 5 (N = 5)RD+/ECPR+n = 8 (N = 9)Maternal outcomes, n (%) Survival to intensive care unit admission51/64 (79.6)63/110 (57.2)5/5 (100)7/8 (87.5) CPR initiation to ROSC time9 (4–22)15 (8–29)28 (26–30)58 (26–86) Mid-term survival46/66 (69.7)69/171 (40.3)5/5 (100)6/8 (75.0) Mid-term favorable neurological outcome37/61 (61.9)39/146 (26.7)4/5 (80.0)2/8 (25.0)Neonatal outcome, N (%) Requirement for ventilation after delivery11/33 (33.3)55/77 (71.4)2/4 (50.0)6/7 (85.7) Requirement for CPR after delivery3/31 (9.6)38/78 (48.7)1/4 (25.0)5/7 (71.4) Survival to intensive care unit admission21/42 (50.0)75/103 (72.8)3/5 (60.0)5/7 (71.4) Mid-term survival29/58 (50.0)61/101 (60.4)3/5 (60.0)4/7 (57.1) Mid-term favorable neurological outcome23/57 (40.3)52/94 (55.3)3/5 (60.0)1/5 (20.0)Amount of RBC transfusion after cardiac arrest (U), median (IQR)15 (8–22)11 (2–37)9 (2–17)54 (41–58)Amount of FFP transfusion after cardiac arrest (U), median (IQR)13 (4–24)8 (0–18)4 (0–7)38 (34–44)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, FFP Fresh frozen plasma, IQR Interquartile range, n N, number, RBC Red blood cell, RD Resuscitative delivery, ROSC Return of spontaneous circulation, U Unitn: Maternal sample sizeN: Neonatal sample size Maternal and neonatal outcomes CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, FFP Fresh frozen plasma, IQR Interquartile range, n N, number, RBC Red blood cell, RD Resuscitative delivery, ROSC Return of spontaneous circulation, U Unit n: Maternal sample size N: Neonatal sample size Neonatal outcomes Ventilation was required in 11/33 (33.3%), 55/77 (71.4%), 2/4 (50.0%), and 6/7 (85.7%) of neonates in the RD–/ECPR–, RD+/ECPR–, RD–/ECPR+, and RD+/ECPR+ groups, respectively. Neonatal CPR was required in 3/31 (9.6%), 38/78 (48.7%), 1/4 (25.0%), and 5/7 (71.4%), respectively. Survival to ICU admission was 21/42 (50.0%), 75/103 (72.8%), 3/5 (60.0%), and 5/7 (71.4%), respectively. Mid-term neonatal survival was 29/58 (50.0%), 61/101 (60.4%), 3/5 (60.0%), and 4/7 (57.1%), with favorable neurological outcomes observed in 23/57 (40.3%), 52/94 (55.3%), 3/5 (60.0%), and 1/5 (20.0%), respectively (Table 2). Transfusion The volume of transfusion following cardiac arrest varied across maternal resuscitation approaches. Median red blood cell units transfused were 15 (IQR, 8–22) in RD–/ECPR–, 11 (IQR, 2–37) in RD+/ECPR–, 9 (IQR, 2–17) in RD–/ECPR+, and 54 (IQR, 41–58) in RD+/ECPR+. Median fresh frozen plasma transfusion followed a similar pattern: 13 (IQR, 4–24), 8 (IQR, 0–18), 4 (IQR, 0–7), and 38 (IQR, 34–44), respectively (Table 2). Subgroup analyses Among cases receiving both RD and ECPR, maternal survival was reported in 5 of 6 cases (83.3%) when ECPR was initiated after RD, with favorable neurological outcomes reported in 4 of 6 cases (66.6%). When ECPR preceded RD, maternal survival and favorable neurological outcome were each reported in one case. Neonatal outcomes in these cases included ventilation support in 5 of 6 neonates (83.3%), neonatal CPR in 4 of 6 neonates (66.6%), and mid-term survival in 1 of 4 neonates (25.0%) (Table 3). Among patients with OHCA, RD+/ECPR + was reported in four cases, with survival documented in three cases and favorable neurological recovery in one case. Among patients with IHCA, RD-/ECPR + was reported in five cases; all survived, and favorable neurological outcomes were documented in four cases (Table 4). Maternal and neonatal outcomes across resuscitation strategies in cases of amniotic fluid embolism are summarized in Table 5, and those in patients with a gestational age of ≥ 20 weeks are summarized in Table 6. Maternal and neonatal outcomes stratified by time period (2000–2009, 2010–2014, 2015–2019, and 2020-) to account for temporal changes in resuscitation practices are shown in Table 7. The use of combined RD and ECPR appeared to increase in more recent periods; however, the number of cases remained limited, precluding meaningful assessment of temporal trends in outcomes. To assess the robustness of the main findings, a sensitivity analysis was performed restricting the population to patients who met commonly used eligibility criteria for ECPR. Within this selected population, maternal survival, neurological outcomes, neonatal outcomes, and transfusion requirements varied across resuscitation strategies, consistent with the overall cohort (Table 8). Table 3Maternal and neonatal outcomes following combined RD and ECPRRD firstVariablesRD+/ECPR+n = 6 (N = 6)ECPR later (n = 6)Maternal outcomes, n (%) Mid-term survival5/6 (83.3) Mid-term favorable neurological outcome4/6 (66.6) Neonatal outcome (N = 6) Requirement for ventilation after delivery5/6 (83.3) Requirement for CPR after delivery4/6 (66.6) Survival to intensive care unit admission4/5 (80.0) Mid-term survival1/4 (25.0) Mid-term favorable neurological outcomeNAECPR firstVariablesRD+/ECPR+n = 1 (N = 1)ECPR first (n = 1)Maternal outcomes, n (%) Mid-term survival1/1 (100) Mid-term favorable neurological outcome1/1 (100)Neonatal outcome Requirement for ventilation after deliveryNA Requirement for CPR after deliveryNA Survival to intensive care unit admission1/1 (100) Mid-term survival1/1 (100) Mid-term favorable neurological outcomeNACPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, n, N, number, RD Resuscitative deliveryn: maternal sample sizeN: neonatal sample size Table 3Maternal and neonatal outcomes following combined RD and ECPRRD firstVariablesRD+/ECPR+n = 6 (N = 6)ECPR later (n = 6)Maternal outcomes, n (%) Mid-term survival5/6 (83.3) Mid-term favorable neurological outcome4/6 (66.6) Neonatal outcome (N = 6) Requirement for ventilation after delivery5/6 (83.3) Requirement for CPR after delivery4/6 (66.6) Survival to intensive care unit admission4/5 (80.0) Mid-term survival1/4 (25.0) Mid-term favorable neurological outcomeNAECPR firstVariablesRD+/ECPR+n = 1 (N = 1)ECPR first (n = 1)Maternal outcomes, n (%) Mid-term survival1/1 (100) Mid-term favorable neurological outcome1/1 (100)Neonatal outcome Requirement for ventilation after deliveryNA Requirement for CPR after deliveryNA Survival to intensive care unit admission1/1 (100) Mid-term survival1/1 (100) Mid-term favorable neurological outcomeNACPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, n, N, number, RD Resuscitative deliveryn: maternal sample sizeN: neonatal sample size Maternal and neonatal outcomes following combined RD and ECPR ECPR later (n = 6) Maternal outcomes, n (%) CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, n, N, number, RD Resuscitative delivery n: maternal sample size N: neonatal sample size Table 4Patient outcomes in OHCA versus IHCA patientsOHCAVariablesRD-/ECPR-n = 28 (N = 28)RD+/ECPR-n = 48 (N = 48)RD-/ECPR+n = 0 (N = 0)RD+/ECPR+n = 4 (N = 4)Maternal outcomes, n (%) Survival to intensive care unit admission19/28 (67.8)18/44 (40.9)NA4/4 (100) CPR initiation to ROSC time (minutes), median (IQR)16 (7–21)22 (10–50)NA75 (19–86) Mid-term survival17/28 (60.7)10/48 (20.8)NA3/4 (75.0) Mid-term favorable neurological outcome11/26 (42.3)8/47 (17.0)NA1/4 (25.0)Neonatal outcome Requirement for ventilation after delivery4/14 (28.5)27/31 (87.1)NA2/2 (100) Requirement for CPR after delivery2/13 (15.3)23/30 (76.6)NA2/2 (100) Survival to intensive care unit admission8/16 (50.0)24/38 (63.1)NA3/3(100) Mid-term survival14/28 (50.0)17/39 (43.5)NA2/4 (50.0) Mid-term favorable neurological outcome12/28 (42.8)12/38 (31.5)NA0/2 (0)IHCAVariablesRD-/ECPR-n = 36 (N = 36)RD+/ECPR-n = 69 (N = 73)RD-/ECPR+n = 5 (N = 5)RD+/ECPR+n = 4 (N = 5)Maternal outcomes, n (%) Survival to intensive care unit admission32/36 (88.9)42/60 (70.0)5/5 (100)3/4 (75.0) CPR initiation to ROSC time (minutes), median (IQR)4 (3–32)14 (8–20)28 (26–30)41 (26–90) Mid-term survival29/36 (80.5)40/67 (59.7)5/5 (100)3/4 (75.0) Mid-term favorable neurological outcome26/33 (78.7)31/62 (50.0)4/5 (80.0)1/4 (12.5)Neonatal outcome Requirement for ventilation after delivery7/19 (36.8)28/46 (60.8)2/4 (50.0)4/5 (80.0) Requirement for CPR after delivery1/15 (5.5)15/48 (31.2)1/4 (25.0)3/5 (60.0) Survival to intensive care unit admission13/26 (50.0)46/59 (77.9)3/5 (60.0)2/4 (50.0) Mid-term survival15/28 (53.5)41/55 (74.5)3/5 (60.0)2/4 (50.0) Mid-term favorable neurological outcome11/27 (40.7)37/49 (75.5)3/5 (60.0)1/3 (33.3)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IHCA In-hospital cardiac arrest, IQR Interquartile range, n N, number, OHCA Out-of-hospital cardiac arrest, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Table 4Patient outcomes in OHCA versus IHCA patientsOHCAVariablesRD-/ECPR-n = 28 (N = 28)RD+/ECPR-n = 48 (N = 48)RD-/ECPR+n = 0 (N = 0)RD+/ECPR+n = 4 (N = 4)Maternal outcomes, n (%) Survival to intensive care unit admission19/28 (67.8)18/44 (40.9)NA4/4 (100) CPR initiation to ROSC time (minutes), median (IQR)16 (7–21)22 (10–50)NA75 (19–86) Mid-term survival17/28 (60.7)10/48 (20.8)NA3/4 (75.0) Mid-term favorable neurological outcome11/26 (42.3)8/47 (17.0)NA1/4 (25.0)Neonatal outcome Requirement for ventilation after delivery4/14 (28.5)27/31 (87.1)NA2/2 (100) Requirement for CPR after delivery2/13 (15.3)23/30 (76.6)NA2/2 (100) Survival to intensive care unit admission8/16 (50.0)24/38 (63.1)NA3/3(100) Mid-term survival14/28 (50.0)17/39 (43.5)NA2/4 (50.0) Mid-term favorable neurological outcome12/28 (42.8)12/38 (31.5)NA0/2 (0)IHCAVariablesRD-/ECPR-n = 36 (N = 36)RD+/ECPR-n = 69 (N = 73)RD-/ECPR+n = 5 (N = 5)RD+/ECPR+n = 4 (N = 5)Maternal outcomes, n (%) Survival to intensive care unit admission32/36 (88.9)42/60 (70.0)5/5 (100)3/4 (75.0) CPR initiation to ROSC time (minutes), median (IQR)4 (3–32)14 (8–20)28 (26–30)41 (26–90) Mid-term survival29/36 (80.5)40/67 (59.7)5/5 (100)3/4 (75.0) Mid-term favorable neurological outcome26/33 (78.7)31/62 (50.0)4/5 (80.0)1/4 (12.5)Neonatal outcome Requirement for ventilation after delivery7/19 (36.8)28/46 (60.8)2/4 (50.0)4/5 (80.0) Requirement for CPR after delivery1/15 (5.5)15/48 (31.2)1/4 (25.0)3/5 (60.0) Survival to intensive care unit admission13/26 (50.0)46/59 (77.9)3/5 (60.0)2/4 (50.0) Mid-term survival15/28 (53.5)41/55 (74.5)3/5 (60.0)2/4 (50.0) Mid-term favorable neurological outcome11/27 (40.7)37/49 (75.5)3/5 (60.0)1/3 (33.3)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IHCA In-hospital cardiac arrest, IQR Interquartile range, n N, number, OHCA Out-of-hospital cardiac arrest, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Patient outcomes in OHCA versus IHCA patients CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IHCA In-hospital cardiac arrest, IQR Interquartile range, n N, number, OHCA Out-of-hospital cardiac arrest, RD Resuscitative delivery, ROSC Return of spontaneous circulation n: maternal sample size N: neonatal sample size Table 5Maternal and neonatal outcomes among AFE patientsAFEVariablesRD-/ECPR-n = 11 (N = 11)RD+/ECPR-n = 14 (N = 15)RD-/ECPR+n = 2 (N = 2)RD+/ECPR+n = 3 (N = 3)Maternal outcomes, n (%) Survival to intensive care unit admission10/11 (90.9)9/14 (64.2)2/2 (100)3/3 (100) CPR initiation to ROSC time (minutes), median (IQR)25 (20–40)17 (14–70)29 (28–30)86 (75–90) Mid-term survival10/11 (90.9)6/14 (42.8)2/2 (100)3/3 (100) Mid-term favorable neurological outcome9/11 (81.8)4/13 (30.7)1/2 (50.0)1/3 (33.3)Neonatal outcome Requirement for ventilation after delivery7/7 (100)7/10 (70.0)1/2 (50.0)3/3 (100) Requirement for CPR after delivery2/6 (33.3)4/11 (36.3)1/2 (50.0)2/3 (66.6) Survival to intensive care unit admission9/10 (90.0)12/13 (92.3)2/2 (100)2/3 (66.6) Mid-term survival7/9 (77.7)8/11 (72.7)2/2 (100)2/3 (66.6) Mid-term favorable neurological outcome4/9 (44.4)7/10 (70.0)2/2 (100)1/3 (33.3)AFE Amniotic fluid embolism, CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Table 5Maternal and neonatal outcomes among AFE patientsAFEVariablesRD-/ECPR-n = 11 (N = 11)RD+/ECPR-n = 14 (N = 15)RD-/ECPR+n = 2 (N = 2)RD+/ECPR+n = 3 (N = 3)Maternal outcomes, n (%) Survival to intensive care unit admission10/11 (90.9)9/14 (64.2)2/2 (100)3/3 (100) CPR initiation to ROSC time (minutes), median (IQR)25 (20–40)17 (14–70)29 (28–30)86 (75–90) Mid-term survival10/11 (90.9)6/14 (42.8)2/2 (100)3/3 (100) Mid-term favorable neurological outcome9/11 (81.8)4/13 (30.7)1/2 (50.0)1/3 (33.3)Neonatal outcome Requirement for ventilation after delivery7/7 (100)7/10 (70.0)1/2 (50.0)3/3 (100) Requirement for CPR after delivery2/6 (33.3)4/11 (36.3)1/2 (50.0)2/3 (66.6) Survival to intensive care unit admission9/10 (90.0)12/13 (92.3)2/2 (100)2/3 (66.6) Mid-term survival7/9 (77.7)8/11 (72.7)2/2 (100)2/3 (66.6) Mid-term favorable neurological outcome4/9 (44.4)7/10 (70.0)2/2 (100)1/3 (33.3)AFE Amniotic fluid embolism, CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Maternal and neonatal outcomes among AFE patients AFE Amniotic fluid embolism, CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulation n: maternal sample size N: neonatal sample size Table 6Maternal and neonatal outcomes in patients with gestational age ≥ 20 weeksGestational age ≥ 20 weeksVariablesRD-/ECPR-n = 43 (N = 43)RD+/ECPR-n = 105 (N = 109)RD-/ECPR+n = 5 (N = 5)RD+/ECPR+n = 8 (N = 9)Maternal outcomes, n (%) Survival to intensive care unit admission36/43 (83.7)61/104 (58.6)5/5 (100)7/8 (87.5) CPR initiation to ROSC time (minutes), median (IQR)9 (4–25)16 (8–29)28 (26–30)58 (26–86) Mid-term survival32/43 (74.4)46/103 (44.6)5/5 (100)6/8 (75.0) Mid-term favorable neurological outcome27/42 (64.2)37/99 (37.3)4/5 (80.0)2/8 (25.0)Neonatal outcome Requirement for ventilation after delivery11/24 (45.8)50/72 (69.4)2/4 (50.0)6/7 (85.7) Requirement for CPR after delivery3/22 (13.6)35/73 (47.9)1/4 (25.0)5/7 (71.4) Survival to intensive care unit admission20/33 (60.6)71/97 (73.2)3/5 (60.0)5/7 (71.4) Mid-term survival23/38 (60.5)59/96 (61.4)3/5 (60.0)4/7 (57.1) Mid-term favorable neurological outcome17/37 (45.9)50/89 (56.1)3/5 (60.0)1/5 (20.0)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Table 6Maternal and neonatal outcomes in patients with gestational age ≥ 20 weeksGestational age ≥ 20 weeksVariablesRD-/ECPR-n = 43 (N = 43)RD+/ECPR-n = 105 (N = 109)RD-/ECPR+n = 5 (N = 5)RD+/ECPR+n = 8 (N = 9)Maternal outcomes, n (%) Survival to intensive care unit admission36/43 (83.7)61/104 (58.6)5/5 (100)7/8 (87.5) CPR initiation to ROSC time (minutes), median (IQR)9 (4–25)16 (8–29)28 (26–30)58 (26–86) Mid-term survival32/43 (74.4)46/103 (44.6)5/5 (100)6/8 (75.0) Mid-term favorable neurological outcome27/42 (64.2)37/99 (37.3)4/5 (80.0)2/8 (25.0)Neonatal outcome Requirement for ventilation after delivery11/24 (45.8)50/72 (69.4)2/4 (50.0)6/7 (85.7) Requirement for CPR after delivery3/22 (13.6)35/73 (47.9)1/4 (25.0)5/7 (71.4) Survival to intensive care unit admission20/33 (60.6)71/97 (73.2)3/5 (60.0)5/7 (71.4) Mid-term survival23/38 (60.5)59/96 (61.4)3/5 (60.0)4/7 (57.1) Mid-term favorable neurological outcome17/37 (45.9)50/89 (56.1)3/5 (60.0)1/5 (20.0)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Maternal and neonatal outcomes in patients with gestational age ≥ 20 weeks CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulation n: maternal sample size N: neonatal sample size Table 7Maternal and neonatal outcomes stratified by time period (2000–2009, 2010–2014, 2015–2019, and 2020-)2000–2009VariablesRD-/ECPR-n = 11 (N = 11)RD+/ECPR-n = 24 (N = 26)RD-/ECPR+n = 1 (N = 1)RD+/ECPR+n = 0 (N = 0)Maternal outcomes, n (%) Survival to intensive care unit admission10/11 (90.9)13/23 (56.5)1/1 (100)NA CPR initiation to ROSC time (minutes), median (IQR)15 (7–21)9 (5–15)30 (30–30)NA Mid-term survival10/11 (90.9)12/22 (54.5)1/1 (100)NA Mid-term favorable neurological outcome10/11 (90.9)9/21 (42.8)0/1 (0)NANeonatal outcome Requirement for ventilation after delivery2/8 (25.0)12/21 (57.1)1/1 (100)NA Requirement for CPR after delivery0/8 (0)7/21 (33.3)1/1 (100)NA Survival to intensive care unit admission5/9 (55.5)21/26 (80.7)1/1 (100)NA Mid-term survival5/8 (62.5)14/20 (70.0)1/1 (100)NA Mid-term favorable neurological outcome5/9 (55.5)13/20 (65.0)1/1 (100)NA2010–2014VariablesRD-/ECPR-n = 18 (N = 18)RD+/ECPR-n = 31 (N = 31)RD-/ECPR+n = 1 (N = 1)RD+/ECPR+n = 1 (N = 1)Maternal outcomes, n (%) Survival to intensive care unit admission16/18 (88.8)9/19 (47.3)1/1 (100)1/1 (100) CPR initiation to ROSC time (minutes), median (IQR)4 (3–25)13 (7–16)49 (49–49)41 (41–41) Mid-term survival16/18 (88.8)9/31 (29.0)1/1 (100)1/1 (100) Mid-term favorable neurological outcome15/17 (88.2)5/27 (18.5)1/1 (100)1/1 (100)Neonatal outcome Requirement for ventilation after delivery4/9 (44.4)12/13 (92.3)0/1 (0)1/1 (100) Requirement for CPR after delivery1/9 (11.1)8/13 (61.5)0/1 (0)1/1 (100) Survival to intensive care unit admission7/13 (53.8)12/14 (85.7)0/1 (0)0/1 (0) Mid-term survival9/14 (68.7)11/16 (68.7)0/1 (0)0/1 (0) Mid-term favorable neurological outcome7/13 (53.8)8/11 (72.7)0/1 (0)0/1 (0)2015–2019VariablesRD-/ECPR-n = 25 (N = 25)RD+/ECPR-n = 60 (N = 60)RD-/ECPR+n = 1 (N = 1)RD+/ECPR+n = 3 (N = 3)Maternal outcomes, n (%) Survival to intensive care unit admission16/25 (64.0)12/19 (63.1)1/1 (100)3/3 (100) CPR initiation to ROSC time (minutes), median (IQR)7 (4–21)18 (10–35)26 (26–26)22 (19–26) Mid-term survival12/25 (48.0)18/59 (30.5)1/1 (100)2/3 (66.6) Mid-term favorable neurological outcome7/22 (31.8)5/47 (10.6)1/1 (100)0/3 (0)Neonatal outcome Requirement for ventilation after delivery3/10 (30.0)10/12 (83.3)NA0/1 (0) Requirement for CPR after delivery1/9 (11.1)8/12 (66.6)NA0/1 (0) Survival to intensive care unit admission3/11 (27.2)8/14 (57.1)0/1 (0)1/1 (100) Mid-term survival8/25 (32.0)9/18 (50.0)0/1 (0)2/2 (100) Mid-term favorable neurological outcome6/25 (24.0)8/18 (44.4)0/1 (0)NA2020-VariablesRD-/ECPR-n = 17 (N = 17)RD+/ECPR-n = 69 (N = 72)RD-/ECPR+n = 2 (N = 2)RD+/ECPR+n = 4 (N = 5)Maternal outcomes, n (%) Survival to intensive care unit admission9/10 (90.0)29/49 (59.1)2/2 (100)3/4 (75.0) CPR initiation to ROSC time (minutes), median (IQR)19 (4–40)20 (8–30)18 (8–28)86 (75–90) Mid-term survival8/12 (66.6)30/59 (50.8)2/2 (100)3/4 (75.0) Mid-term favorable neurological outcome5/11 (45.4)20/51 (39.2)2/2 (100)1/4 (25.0)Neonatal outcome Requirement for ventilation after delivery2/6 (33.3)21/31 (67.7)1/2 (50.0)5/5 (100) Requirement for CPR after delivery1/5 (20.0)15/32 (46.8)0/2 (0)4/5 (80.0) Survival to intensive care unit admission6/9 (66.6)34/49 (69.3)2/2 (100)4/5 (80.0) Mid-term survival7/11 (63.6)27/47 (57.4)2/2 (100)2/4 (50.0) Mid-term favorable neurological outcome5/10 (50.0)23/45 (51.1)2/2 (100)1/4 (25.0)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Table 7Maternal and neonatal outcomes stratified by time period (2000–2009, 2010–2014, 2015–2019, and 2020-)2000–2009VariablesRD-/ECPR-n = 11 (N = 11)RD+/ECPR-n = 24 (N = 26)RD-/ECPR+n = 1 (N = 1)RD+/ECPR+n = 0 (N = 0)Maternal outcomes, n (%) Survival to intensive care unit admission10/11 (90.9)13/23 (56.5)1/1 (100)NA CPR initiation to ROSC time (minutes), median (IQR)15 (7–21)9 (5–15)30 (30–30)NA Mid-term survival10/11 (90.9)12/22 (54.5)1/1 (100)NA Mid-term favorable neurological outcome10/11 (90.9)9/21 (42.8)0/1 (0)NANeonatal outcome Requirement for ventilation after delivery2/8 (25.0)12/21 (57.1)1/1 (100)NA Requirement for CPR after delivery0/8 (0)7/21 (33.3)1/1 (100)NA Survival to intensive care unit admission5/9 (55.5)21/26 (80.7)1/1 (100)NA Mid-term survival5/8 (62.5)14/20 (70.0)1/1 (100)NA Mid-term favorable neurological outcome5/9 (55.5)13/20 (65.0)1/1 (100)NA2010–2014VariablesRD-/ECPR-n = 18 (N = 18)RD+/ECPR-n = 31 (N = 31)RD-/ECPR+n = 1 (N = 1)RD+/ECPR+n = 1 (N = 1)Maternal outcomes, n (%) Survival to intensive care unit admission16/18 (88.8)9/19 (47.3)1/1 (100)1/1 (100) CPR initiation to ROSC time (minutes), median (IQR)4 (3–25)13 (7–16)49 (49–49)41 (41–41) Mid-term survival16/18 (88.8)9/31 (29.0)1/1 (100)1/1 (100) Mid-term favorable neurological outcome15/17 (88.2)5/27 (18.5)1/1 (100)1/1 (100)Neonatal outcome Requirement for ventilation after delivery4/9 (44.4)12/13 (92.3)0/1 (0)1/1 (100) Requirement for CPR after delivery1/9 (11.1)8/13 (61.5)0/1 (0)1/1 (100) Survival to intensive care unit admission7/13 (53.8)12/14 (85.7)0/1 (0)0/1 (0) Mid-term survival9/14 (68.7)11/16 (68.7)0/1 (0)0/1 (0) Mid-term favorable neurological outcome7/13 (53.8)8/11 (72.7)0/1 (0)0/1 (0)2015–2019VariablesRD-/ECPR-n = 25 (N = 25)RD+/ECPR-n = 60 (N = 60)RD-/ECPR+n = 1 (N = 1)RD+/ECPR+n = 3 (N = 3)Maternal outcomes, n (%) Survival to intensive care unit admission16/25 (64.0)12/19 (63.1)1/1 (100)3/3 (100) CPR initiation to ROSC time (minutes), median (IQR)7 (4–21)18 (10–35)26 (26–26)22 (19–26) Mid-term survival12/25 (48.0)18/59 (30.5)1/1 (100)2/3 (66.6) Mid-term favorable neurological outcome7/22 (31.8)5/47 (10.6)1/1 (100)0/3 (0)Neonatal outcome Requirement for ventilation after delivery3/10 (30.0)10/12 (83.3)NA0/1 (0) Requirement for CPR after delivery1/9 (11.1)8/12 (66.6)NA0/1 (0) Survival to intensive care unit admission3/11 (27.2)8/14 (57.1)0/1 (0)1/1 (100) Mid-term survival8/25 (32.0)9/18 (50.0)0/1 (0)2/2 (100) Mid-term favorable neurological outcome6/25 (24.0)8/18 (44.4)0/1 (0)NA2020-VariablesRD-/ECPR-n = 17 (N = 17)RD+/ECPR-n = 69 (N = 72)RD-/ECPR+n = 2 (N = 2)RD+/ECPR+n = 4 (N = 5)Maternal outcomes, n (%) Survival to intensive care unit admission9/10 (90.0)29/49 (59.1)2/2 (100)3/4 (75.0) CPR initiation to ROSC time (minutes), median (IQR)19 (4–40)20 (8–30)18 (8–28)86 (75–90) Mid-term survival8/12 (66.6)30/59 (50.8)2/2 (100)3/4 (75.0) Mid-term favorable neurological outcome5/11 (45.4)20/51 (39.2)2/2 (100)1/4 (25.0)Neonatal outcome Requirement for ventilation after delivery2/6 (33.3)21/31 (67.7)1/2 (50.0)5/5 (100) Requirement for CPR after delivery1/5 (20.0)15/32 (46.8)0/2 (0)4/5 (80.0) Survival to intensive care unit admission6/9 (66.6)34/49 (69.3)2/2 (100)4/5 (80.0) Mid-term survival7/11 (63.6)27/47 (57.4)2/2 (100)2/4 (50.0) Mid-term favorable neurological outcome5/10 (50.0)23/45 (51.1)2/2 (100)1/4 (25.0)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Maternal and neonatal outcomes stratified by time period (2000–2009, 2010–2014, 2015–2019, and 2020-) CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulation n: maternal sample size N: neonatal sample size Table 8Sensitivity analysis - outcomes among patients with witnessed cardiac arrest, patients who received bystander CPR, and patients with initial shockable rhythmVariablesRD-/ECPR-n = 15 (N = 15)RD+/ECPR-n = 41 (N = 42)RD-/ECPR+n = 2 (N = 2)RD+/ECPR+n = 3 (N = 4)Maternal outcomes, n (%) Survival to intensive care unit admission14/15 (93.3)26/41 (63.4)2/2 (100)2/3 (66.6) CPR initiation to ROSC time (minutes), median (IQR)12 (3–32)18 (8–29)29 (28–30)33 (26–41) Mid-term survival14/15 (93.3)22/41 (53.6)2/2 (100)2/3 (66.6) Favorable neurological outcome at hospital discharge or 30 days12/14 (85.7)18/39 (46.1)1/2 (50.0)1/3 (33.3)Neonatal outcome Requirement for ventilation after delivery5/9 (55.5)26/33 (78.7)1/2 (50.0)3/4 (75.0) Requirement for CPR after delivery0/8 (0)17/32 (53.1)1/2 (50.0)3/4 (75.0) Survival to intensive care unit admission8/14 (57.1)29/40 (72.5)2/2 (100)2/3 (66.6) Mid-term survival8/13 (61.5)25/38 (65.7)2/2 (100)1/3 (66.6) Mid-term favorable neurological outcome7/13 (53.8)24/37 (64.8)2/2 (100)0/2 (0)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Table 8Sensitivity analysis - outcomes among patients with witnessed cardiac arrest, patients who received bystander CPR, and patients with initial shockable rhythmVariablesRD-/ECPR-n = 15 (N = 15)RD+/ECPR-n = 41 (N = 42)RD-/ECPR+n = 2 (N = 2)RD+/ECPR+n = 3 (N = 4)Maternal outcomes, n (%) Survival to intensive care unit admission14/15 (93.3)26/41 (63.4)2/2 (100)2/3 (66.6) CPR initiation to ROSC time (minutes), median (IQR)12 (3–32)18 (8–29)29 (28–30)33 (26–41) Mid-term survival14/15 (93.3)22/41 (53.6)2/2 (100)2/3 (66.6) Favorable neurological outcome at hospital discharge or 30 days12/14 (85.7)18/39 (46.1)1/2 (50.0)1/3 (33.3)Neonatal outcome Requirement for ventilation after delivery5/9 (55.5)26/33 (78.7)1/2 (50.0)3/4 (75.0) Requirement for CPR after delivery0/8 (0)17/32 (53.1)1/2 (50.0)3/4 (75.0) Survival to intensive care unit admission8/14 (57.1)29/40 (72.5)2/2 (100)2/3 (66.6) Mid-term survival8/13 (61.5)25/38 (65.7)2/2 (100)1/3 (66.6) Mid-term favorable neurological outcome7/13 (53.8)24/37 (64.8)2/2 (100)0/2 (0)CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulationn: maternal sample sizeN: neonatal sample size Sensitivity analysis - outcomes among patients with witnessed cardiac arrest, patients who received bystander CPR, and patients with initial shockable rhythm CPR Cardiopulmonary resuscitation, ECPR Extracorporeal cardiopulmonary resuscitation, IQR Interquartile range, n N, number, RD Resuscitative delivery, ROSC Return of spontaneous circulation n: maternal sample size N: neonatal sample size Quality assessment Quality assessment findings are summarized in Additional File 3, 4, 5. Most case reports and case series met key JBI appraisal criteria, with generally adequate reporting of patient characteristics, interventions, and outcomes, although some methodological details were unclear. Observational studies demonstrated heterogeneous risk-of-bias ratings across QUIPS domains, with variability in confounding control, follow-up completeness, and outcome measurement. Overall, the quality of the included literature was mixed but sufficient to support descriptive synthesis. Discussion This systematic review synthesizes the largest body of published evidence to date describing maternal and neonatal outcomes after cardiac arrest in pregnancy, stratified by initial resuscitation strategy, including conventional CPR, RD, ECPR, and combined RD/ECPR approaches. By integrating reports spanning approximately 25 years and multiple healthcare systems, this review provides a comprehensive descriptive overview of how maternal and neonatal outcomes have been reported across different resuscitation strategies in an extremely rare clinical scenario. Survivors with favorable outcomes were reported across different initial resuscitation strategies, including conventional CPR, RD, ECPR, and combined RD/ECPR. However, these observations are derived from small numbers of highly selected cases and should be interpreted cautiously. Moreover, the predominance of case series and reports, which may result in an overestimation of survival rates relative to those observed in the real-world settings. Our findings underscore the considerable variability in the use of ECPR and RD in the initial management of maternal cardiac arrest and highlight the need for additional research to establish optimal initial resuscitation strategies for this population. The maternal and neonatal outcomes observed in this systematic review should be interpreted in the context of existing literature on maternal cardiac arrest, RD, and ECPR. Previous systematic reviews of OHCA reported maternal survival rates of approximately 4.5% following RD, with relatively favorable neonatal outcomes compared to maternal outcomes [1]. These OHCA cohorts were characterized by low rates of witnessed arrest and delays in RD implementation, factors that likely contributed to poorer maternal survival. Consistent with our findings, maternal survival after OHCA is generally lower than that after IHCA, reflecting delays in recognition and limited access to timely advanced resuscitative measures [3]. In contrast, maternal cardiac arrest has been reported to be associated with higher survival rates compared with cardiac arrest in non-pregnant patients, a difference that is thought to be partly attributable to closer physiological monitoring, a higher likelihood of witnessed arrest, and earlier initiation of resuscitative interventions [23, 24]. However, Einav et al. emphasized that the effectiveness of resuscitative hysterotomy is highly time-dependent, with improved maternal and neonatal outcomes when performed early after arrest. The apparent limited survival benefit in some cases may reflect delayed intervention, irreversible etiologies, or prolonged no-flow intervals rather than ineffectiveness of the procedure itself [25]. Studies evaluating the timing of RD suggest that progressively longer intervals from cardiac arrest to delivery are associated with worse maternal and neonatal outcomes, even with incremental delays measured in minutes [26]. Survival also appears to vary according to the use and indication for ECMO, and relatively high survival rates have been reported in selected patients who received ECMO during cardiac arrest [27]. Current resuscitation guidelines acknowledge that ECPR as a potential rescue option in highly selected pregnant patients with refractory cardiac arrest after standard resuscitative measures, including RD, have failed to achieve ROSC [5, 6]. However, these recommendations emphasize the scarceness of pregnancy-specific outcome data and the need for individualized, context-dependent decision-making. In addition, we performed a stratified analysis by calendar period to explore temporal trends. Over the past 25 years, resuscitation practices for maternal cardiac arrest have evolved substantially, reflecting major changes in international guidelines. Pregnancy-specific considerations were incorporated in 2000, including the “four-minute rule” recommending early resuscitative delivery in the absence of ROSC [14]. The 2010 guidelines introduced a paradigm shift from ABC to CAB sequencing with an emphasis on high-quality chest compressions, and subsequent updates further reinforced high-quality CPR and continuous evidence-based refinement [28, 29]. In recent years, advanced strategies such as RD and ECPR have been increasingly recognized, and the use of ECPR, alone or in combination with RD, appeared to increase over time [30]. Improvements in bystander CPR rates and survival have also been reported in association with public health initiatives [31]. However, temporal changes in ROSC, survival, and neurological outcomes could not be reliably assessed due to the limited number of cases and the inherent publication bias of case-based literature. These factors may have influenced both treatment selection and outcomes, potentially confounding comparisons across time periods. One of the findings of this systematic review is a lack of data on how ECPR and RD should be integrated and sequenced in maternal cardiac arrest. Although RD has traditionally been advocated during conventional CPR to relieve aortocaval compression and improve maternal hemodynamics [32], its incremental circulatory benefit once ECMO support has been established remains uncertain. After ECPR initiation, systemic perfusion is largely maintained by ECMO flow rather than cardiac output, potentially attenuating the hemodynamic advantage conferred by uterine evacuation. On the contrary, early initiation of ECPR may provide theoretical benefits by rapidly restoring cerebral and systemic perfusion, thereby shortening low-flow duration and potentially preserving neurological function. Uterine enlargement may potentially impede femoral cannulation, alter vascular anatomy, and thereby increase the risk of vascular or retroperitoneal injury [33]. Moreover, the requirement for systemic anticoagulation during ECPR introduces a substantial hemorrhagic risk in the peripartum setting [1]. Large obstetric ECMO studies have reported severe bleeding in approximately 15% of patients [27]. Importantly, in our review, patients who underwent combined ECPR and RD exhibited the highest transfusion requirements, underscoring the considerable hemorrhagic burden associated with this strategy. This finding highlights that decisions regarding the sequencing of ECPR and RD must balance potential neurological benefits against procedural feasibility and bleeding risk. Only a limited number of reports have explicitly described the timing and order of ECPR and RD, and the available cases were insufficient to permit meaningful comparative analysis. Collectively, the absence of comparative evidence, together with the competing priorities of maternal cerebral perfusion, fetal viability, and hemorrhagic risk, underscore a critical knowledge gap. Prospective, standardized data collection through dedicated registries is essential to clarify the optimal integration and sequencing of advanced resuscitative interventions in maternal cardiac arrest. Limitations Our study has several limitations. First, the available data was predominantly derived from case reports and case series, resulting in a paucity of high-quality data. Consequently, the findings are susceptible to publication bias, as cases with favorable outcomes are more likely to be reported, whereas patients with poor outcomes may be underrepresented. Second, although some observational studies reported maternal or neonatal outcomes, study eligibility was limited by incomplete reporting of the initial resuscitation strategy. In addition, the lack of detailed information regarding the type, timing, and sequence of resuscitative interventions limited study inclusion and may have reduced the completeness of the available evidence. Third, the available data were insufficient to support quantitative synthesis or meta-analysis. Substantial heterogeneity in study design, outcome definitions, and reporting, together with small sample sizes, precluded meaningful statistical pooling. Fourth, even among the included observational studies, patient-level baseline characteristics were incompletely reported, limiting adjustment for potential confounders and interpretation of outcomes across different resuscitation strategies. To address missing data on patient outcomes and clinical details, we contacted the corresponding authors; however, no informative or analyzable responses were obtained. Fifth, although four databases were searched, one was a Japan-specific database that primarily indexes Japanese-language publications. Consequently, studies from Japan were overrepresented, which may limit the generalizability of the findings to other healthcare systems and clinical settings. Finally, given the extremely small number of cases reporting the sequence of ECPR and RD, comparative evaluation of maternal and neonatal outcomes according to intervention order was not feasible. Further research using large, dedicated databases is warranted to better define optimal resuscitation strategies and to improve neonatal survival in maternal cardiac arrest. Conclusions In this systematic review of 268 reported cases of maternal cardiac arrest, maternal and neonatal outcomes varied widely across resuscitation approaches. Favorable maternal survival and neurological outcomes have been reported in a small number of cases involving ECPR; however, the limited case numbers and predominance of case-based evidence preclude causal inference, underscoring the need for prospective registries and multicenter studies to define the optimal timing and sequencing of advanced interventions such as ECPR and RD. Supplementary Information Supplementary Material 1. Additional File 1: Full search terms. Supplementary Material 1. Additional File 1: Full search terms. Supplementary Material 2. Additional File 2: Summary of the literature. Supplementary Material 2. Additional File 2: Summary of the literature. Supplementary Material 3. Additional File 3: Quality assessment of case reports. Supplementary Material 3. Additional File 3: Quality assessment of case reports. Supplementary Material 4. Additional File 4: Quality assessment of case series. Supplementary Material 4. Additional File 4: Quality assessment of case series. Supplementary Material 5. Additional File 5: Quality assessment of observational studies. Supplementary Material 5. Additional File 5: Quality assessment of observational studies.